The Impact of Patient-Reported Outcomes in Market Access: A Literature Review, Regulatory Evidence Assessment Framework and Study

The Cancer Drugs Fund in Practice and Under the New Framework

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review

The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes

An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England

Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke

Assessing the Quality and Coherence of Network Meta-Analyses of Biologics in Plaque Psoriasis: What Does All This Evidence Synthesis Tell Us?

Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year

Cost-Effectiveness of Vagus Nerve Stimulation for Treatment-Resistant Depression in the United Kingdom

Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries.

Cost-effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium

Systematic literature review and network meta-analysis of sodium-glucoses co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes

Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules

Genomic surveillance of methicillin-resistant Staphylococcus aureus: a mathematical early modelling study of cost effectiveness

Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation.

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response

Cost effectiveness of an insertable cardiac monitor in a high-risk population in the UK

Indirect Treatment Comparisons and Network Meta-Analyses of Naldemedine for the Treatment of Opioid-Induced Constipation

Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis

Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response

The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis

Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life

Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features

Evidence in support of hyperkalaemia management strategies: A systematic literature review. International journal of clinical practice

Systematic Literature Review and Network Meta-Analysis of SGLT-2 Inhibitors and Metformin as Add-On to Insulin for the Treatment of Type 1 Diabetes

A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK

A Network Meta-Analysis to Evaluate The Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis

Assessing the Longer-Term Efficacy of Biologic Therapies and Apremilast for Patients with Moderate-To-Severe Psoriasis: A Systematic Review and Network Meta-Analysis

How Do Nice Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

Exploring Concurrent Validity of The CLN2 Clinical Rating Scale: Comparison To Pedsql Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents: An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis Techniques

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

Tocilizumab in Methotrexate-Naive Rheumatoid Arthritis – A Cost-Utility Model for Slovakia

Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis

Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK

Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes

Mabthera (Rituximab) for the Treatment of Severe Granulomatosis With Polyangiitis (Gpa) and Microscopic Polyangiitis (Mpa) – A Cost-Utility Model for the United Kingdom

Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis: An Indirect Comparison

An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

Early management of head injury: summary of updated NICE guidance

Cost-utility of tocilizumab in the treatment of systemic juvenile idiopathic arthritis in Finland

Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain

Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses

Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom

Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis. Br J Dermatol

Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder I Patients with Mixed Episodes

Validity of cost and utility results?

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective

Economic evaluation of tocilizumab combination in the treatment of moderate to severe rheumatoid arthritis in Italy

Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer’s Perspective

Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer’s perspective

Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden

Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance

Guideline Development G. Assessment and management of psoriasis: summary of NICE guidance

Management of acute upper gastrointestinal bleeding: summary of NICE guidance

The evolution of global health teaching in undergraduate medical curricula

Conceptualising global health: theoretical issues and their relevance for teaching

An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement

Cost-Effectiveness of Rivaroxaban versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Canada

Guideline Development G. Management of bedwetting in children and young people: summary of NICE guidance

Influence of salts and natural organic matter on the stability of bacteriophage MS2

Aggregation kinetics of cerium oxide nanoparticles in monovalent and divalent electrolytes. Colloids and Surfaces A: Physicochemical and Engineering Aspects

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland and the United Kingdom

A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK